ACTL6A and neoplasm: As shown in Table 1, high levels of ACTL6A protein were significantly associated with FIGO stage (p < 0.01) and differentiation grades (p < 0.01), but not with tumor size (p = 0.452), deep stromal invasion (p = 0.146) and patient age (p = 0.061).